Modular design of optically controlled protein affinity reagents

Chem Commun (Camb). 2018 Feb 8;54(13):1591-1594. doi: 10.1039/c7cc07391g.

Abstract

Photopharmaceuticals can, in principle, be created by linking photoswitchable moieties to bioactive molecules. However, a general strategy for converting a therapeutic agent into its photoswitchable version is not currently available. Herein we propose a generalizable, modular approach for obtaining light controllable bioactive agents by modifying the scaffold of a protein affinity reagent using an azobenzene photoswitch.

MeSH terms

  • Azo Compounds / chemistry
  • Azo Compounds / radiation effects
  • Chymases / antagonists & inhibitors
  • Cross-Linking Reagents / chemistry
  • Cross-Linking Reagents / radiation effects
  • Humans
  • Peptide Fragments / chemistry*
  • Peptide Fragments / radiation effects
  • Photoaffinity Labels / chemistry*
  • Photoaffinity Labels / radiation effects
  • Protein Folding / drug effects
  • Proto-Oncogene Proteins c-fyn / chemistry*
  • Proto-Oncogene Proteins c-fyn / radiation effects
  • Sulfanilic Acids / chemistry
  • Sulfanilic Acids / radiation effects
  • Ultraviolet Rays

Substances

  • 3,3'-bis(sulfonato)-4,4'-bis(chloroacetamide)azobenzene
  • Azo Compounds
  • Cross-Linking Reagents
  • Peptide Fragments
  • Photoaffinity Labels
  • Sulfanilic Acids
  • FYN protein, human
  • Proto-Oncogene Proteins c-fyn
  • Chymases